Natural products targeting the gut microbiota-barrier-immune axis in inflammatory bowel disease: Mechanisms, clinical evidence, and therapeutic potential
Yuan Wang, Rong-ying Fan, Yu-zhen Dang, Ji-li Han, Jing-ting Zhang, Rui-ze Liu et al. Natural products targeting the gut microbiota-barrier-immune axis in inflammatory bowel disease: Mechanisms, clinical evidence, and therapeutic potential. // Pharmacological Research - Reports. – 2026. – DOI: 10.1016/j.prerep.2026.100098. – URL: https://doi.org/10.1016/j.prerep.2026.100098
Yuan Wang, Rong-ying Fan, Yu-zhen Dang, Ji-li Han, Jing-ting Zhang, Rui-ze Liu, Zong-yu Li, Yue Ren, Run-yu Yang, Cui-ling Wang, & Rui-ping Zhang (2026). Natural products targeting the gut microbiota-barrier-immune axis in inflammatory bowel disease: Mechanisms, clinical evidence, and therapeutic potential. Pharmacological Research - Reports. https://doi.org/10.1016/j.prerep.2026.100098
Yuan Wang, et al. “Natural products targeting the gut microbiota-barrier-immune axis in inflammatory bowel disease: Mechanisms, clinical evidence, and therapeutic potential.” Pharmacological Research - Reports, 2026. doi:10.1016/j.prerep.2026.100098.
@article{Wang2026,
title = {Natural products targeting the gut microbiota-barrier-immune axis in inflammatory bowel disease: Mechanisms, clinical evidence, and therapeutic potential},
author = {Wang, Yuan and Fan, Rong-ying and Dang, Yu-zhen and Han, Ji-li and Zhang, Jing-ting and Liu, Rui-ze and Li, Zong-yu and Ren, Yue and Yang, Run-yu and Wang, Cui-ling and Zhang, Rui-ping},
journal = {Pharmacological Research - Reports},
year = {2026},
doi = {10.1016/j.prerep.2026.100098},
url = {https://doi.org/10.1016/j.prerep.2026.100098}
}